Speakers at Gene Drives: Technologies, applications & biosafety challenges
Gene Drives: Technologies, applications & biosafety challenges
About the speakers
-
Fred Wassenaar
Working address:
P.O. Box 1
3720 BA Bilthoven
The NetherlandsTel: +31 6 4686 0957
Email: fred.wassenaar@rivm.nl
Academic Education and Degrees
1980 BSc : Van Leeuwenhoek Institute Delft (Rotterdam University of Applied Sciences), The Netherlands
Experience and courses:
- Biosafety Officer and Senior Biosafety Advisor,
- Risk assessment of Contained Use of GMOs (Directive 2009/41/EC), accreditation of Biological Safety Professionals for GMO, Biosafety education and training (courses, workshops),
-
human genetics (start DNA diagnostics in the Netherlands),
-
enzyme purification (from cyanobacteria),
-
immunology (TCR),
-
virology (parvovirus B19, baculovirus, HCV, arteriviruses, coronaviruses),
-
teacher (practical courses on cell culture, virology, gmo’s, risk assessment),
-
occupational health, biosafety and biosecurity (risk assessment and legislation)
at Leiden University (with an intermezzo for two years at Promega), Leiden University Medical Center, and the Dutch National Institute for Public Health and the Environment.
-
Patrick Rüdelsheim
Academic Education and Degrees
- PhD in biology/botany at the University of Antwerp, Belgium
Present Professional Position
General Manager, Partner at PERSEUS BV
PERSEUS offers efficient solutions for biorisk management and regulatory compliance.
Biorisk management covers all aspects of biological safety and security such as risk assessment, containment requirements, training, audit, transport, waste handling and emergency preparedness. PERSEUS experts can act as external biosafety officers to your organisation.
PERSEUS integrates technical background with an in depth knowledge of the European regulatory requirements for biological material, including genetically modified organisms. We assist clients in complying with complex regulatory requirements on contained use, workers protection, pathogens, import and export, emergency planning, deliberate releases such as field trials and clinical trials and commercial applications.
Special Remarks
- First-hand experience in obtaining approvals for and performing activities with genetically modified organisms in EU and internationally
- Involved in public biosafety research collaborations and in corporate product defence
- Recognized risk assessment and management expert
- Active member of key biosafety associations and working groups (EBSA, ISBR, BBP)
- Fully independent service provider since 2003